Laboratory Medicine and Quality Assurance

Table. 2.

Critical differences based on biological variation (III)

Items Unit Selected BV and CD Westgard BV Database [6]


Mean CVI (%) CVG (%) CVA (%) CD (%) Reference CVI (%) CVG (%) CVA (%)
AFP μg/L 3.9 12.4 45.1 7.1 39.6 [14] 12.2 45.6 4.0
CA125 kU/L 12.3 9.1 10.6 2.0 25.8 [15] 24.7 54.6 8.2
CA15-3 U/L - 6.2 62.9 11.2 35.5 [16] 6.1 62.9 2.0
CA19-9 U/mL 5.1 27.2 64.2 5.4 76.8 [17] 16.0 130.5 5.3
CEA μg/L 1.014 30.9 37.1 3.8 86.2 [17] 12.7 55.6 4.2
PSA, total μg/L 0.85 6.8 42.0 3.3 20.9 [18] 18.1 72.4 6.0
Free PSA μg/L 0.32 7.1 46.2 1.4 20.0 [18] - - -
T3 nmol/µg 2.31 6.6 17.2 - 18.3 [19] 6.9 12.3 2.3
T4 mmol/L 133 14.5 3.0 6.2 43.7 [20] 4.9 10.9 1.6
Free T4 pmol/L 18.1 9.1 14.0 5.1 28.9 [20] 5.7 12.1 1.9
Thyroglobulin μg/L 5.1 16.2 128.0 2.9 45.6 [21] 14.0 39.0 4.6
TSH mIU/L 2.19 28.0 61.9 4.4 78.5 [20] 19.3 24.6 6.4
Estradiol pmol/L - 15.0 13.0 8.0 47.1 [22] 22.5 24.4 7.4
FSH IU/L - 11.0 49.0 3.0 31.6 [22] 11.0 47.2 3.6
LH IU/L - 22.0 27.0 3.0 61.5 [22] 23.0 27.4 7.6
Testosterone ng/dL 11.9 18.7 33.6 6.0 54.4 [23] 9.3 22.1 3.1
Prolactin mIU/L 136 23.0 27.0 2.8 64.2 [24] 23.0 35.0 7.6

Abbreviations: BV, biological variation; CD, critical difference; CVI, within-subject biological coefficient of variation; CVG, between-subject biological coefficient of variation; CVA, analytical coefficient of variation; AFP, alpha-fetoprotein; CA, cancer antigen; CEA, carcinoembryonic antigen; PSA, prostate-specific antigen; T3, tri-iodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone

Lab Med Qual Assur 2022;44:88~98 https://doi.org/10.15263/jlmqa.2022.44.2.88
© Lab Med Qual Assur